U.S. Securities and Exchange Commission
Form 10-Q/A
Amendment No. 1
x QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2009
OR
o TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE EXCHANGE ACT
For the transition period from to
MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)
|
COLORADO |
|
84-0872291 |
|
(State or other Jurisdiction of |
|
(I.R.S. Employer |
|
Incorporation or Organization) |
|
Identification No.) |
|
12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO |
|
80228 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Issuer’s telephone number, including area code: (303) 987-8000
Check whether the Issuer (1) filed all reports required to be filed by Section 13 or 15 (d) of the Exchange Act, during the past 12 months and (2) has been subject to the filing requirements for the past 90 days. Yes x No o.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of the chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES o NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):
|
Large accelerated filer o |
|
Accelerated filer o |
|
|
|
|
|
Non-accelerated filer o (Do not check if a smaller reporting company) |
|
Smaller reporting company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
State the number of shares outstanding of each of the Issuer’s classes of common stock, as of the latest practicable date:
There were 3,194,030 shares of the Issuer’s common stock, no par value, outstanding as of July 31, 2009.
EXPLANATORY NOTE
This quarterly report on Form 10-Q is being amended in Item 6. Exhibits and Reports on Form 8-K solely for the purpose of filing amended and currently dated Certifications as Exhibits 31.1 and 31.2.
Item 6(a) Exhibits
a) Exhibits:
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
MESA LABORATORIES, INC.
JUNE 30, 2009
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Issuer has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MESA LABORATORIES, INC. |
|
|||
|
(Issuer) |
|
|||
|
|
|
|||
|
|
|
|||
|
DATED: |
May 28, 2010 |
|
BY: |
/s/ John J. Sullivan, Ph.D. |
|
|
|
|
|
John J. Sullivan, Ph.D. |
|
|
|
|
|
Chief Executive Officer, |
|
|
|
|
|
President and Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
DATED: |
May 28, 2010 |
|
BY: |
/s/ Steven W. Peterson |
|
|
|
|
|
Steven W. Peterson |
|
|
|
|
|
Vice President-Finance, Chief Financial and Accounting Officer and Secretary |